On [**2146-3-29**], the patient spiked a temperature to 103.4 with a WBC of 14.7 .
At the time of her temperature spike, the patient had a UA that was positive for LE with 10-20 WBCs although not a clean sample with [**3-6**] epithelial cells.
She was treated for a presumed UTI with urine cultures and blood cultures pending.
On [**2146-4-3**], the patient developed acute-onset shortness of breath with mid-sternal [**4-8**] chest pressure that resolved on its own that the patient states she believes was due to anxiety and productive cough of greenish sputum.
A VQ scan was obtained given the patient's recent insufficiency at 1.4-1.6 which was low prob for a PE in the setting of a D-dimer post-operatively of 4200.
A cardiology consult was considered but not formerly placed prior to transfer.
CXR showed LLL atelectasis.
ABG prior to transfer was 7.45/35/241 on 100% NRB.
CXR was did not reveal CHF or PNA and a CTA was performed to r/o PE.
It was negative for PE but did reveal b/l pleural effusions with atelectasis and emphysema and questionable small area of devloping PNA, and an Echo with Ef>55%, normal RV size and motionShe as strted on levo/flagyl and continued on nebs with significant improvemnt in her O2 sats to 95 % on 6 L FM.
COPD [**November 2144**] FEV1 1.46 L FEV1/FVC of 61 c/w mod COPD 5.
Oral HSV 9.
12.?Mild AS by echo per patient  Social History: previous smoker, quit 16 yrs ago but 2 ppd x 30 yrs prior; no EtOH intake, no IVDA.
Family History: NC  Physical Exam: T 98.4 P 97 BP = 112/60 RR = 16 O2 sat = 98% on 6 L face mask Gen- Elderly female sitting in bed able to talk in complete sentences, no accessory respiratory muscle use, very pleasant, alert and oriented x 3 HEENT - crusting lesions, right forehead with yellow, crusty macules, malar eminences with confluent, erythematous blanching rash, no JVD.
[**4-6**] CT OF THE CHEST WITHOUT AND WITH IV CONTRAST: No evidence of pulmonary embolism.
Left ventricular wall thicknesses are normal.
Overall left ventricular systolic function is normal (LVEF>55%).
[**4-16**] CXR: A single AP upright view at 14 hours is compared to previous examination a day ago.
The lungs are clear with changes of emphysema.
The two nodular opacities seen in the right base are likely due to vasculature since there is no corresponding pulmonary abnormality on the recent CT scan dated [**2146-4-4**].
[**4-18**]: CBC: WBC 12.5 hct 24.3 plt 346 Chem 10: Na 135, K 4.3, CL 104, CO2 25, BUN 13, creat 0.8, Ca 7.3, mag 1.9, phos 3.2.
Multiple BCX, UCX since [**4-4**] to [**4-18**] negative to date.
She was treated for a COPD flare as chest x-ray was negative for CHF and pneumonia.
The patient was ruled out PE with CTA of chest but showed b/l pleural effusions with atelectasis and emphysema and ?small area of developing PNA.
Echo was done with EF of 60%.
She was extubated the next day but remained tachypneic with O2 sats improved to 95% on 6L FM and was started empirically on Levo/Flagyl for ?PNA and completed course on [**4-15**] (8 day course).
CXR revealed no CHF or infiltrates.
Pt will need to f/u wtih Dr. [**Last Name (STitle) 64107**] in [**Hospital **] clinic in 1month after discharge for repeat spoke exam to check vocal cord function.
[**Initials (NamePattern4) 22721**] [**Last Name (NamePattern4) **] rash: The patient developed [**Initials (NamePattern4) 22721**] [**Last Name (NamePattern4) **] lesions after getting CEFAZOLIN at OSH.
Left hip wound need to be monitored for any signs of infection.
Lidocaine viscous 2% 20 mL TID for oral ulcers 7.
Sodium Chloride 0.65 % Aerosol, Spray Sig: Four (4) Spray Nasal QID (4 times a day) as needed for 2 weeks.
Cholecalciferol (Vitamin D3) 400 unit Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Beclomethasone Diprop Monohyd 0.042 % Aerosol, Spray Sig: One (1) Spray Nasal [**Hospital1 **] (2 times a day).
Diastolic CHF 5.
[**Initials (NamePattern4) 22721**] [**Last Name (NamePattern4) **] syndrome secondary to Cefazolin 6.
SLE 8. s/p L femoral fracture and revision of ORIF 9.
Osteoporosis 10.
Followup Instructions: Follow-up with ENT in 1 month  Follow-up with Ortho: Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern1) 2235**], MD Phone:[**Telephone/Fax (1) 1228**] Date/Time:[**2146-5-10**] 10:20  Follow-up with PCP [**Last Name (NamePattern4) **] 1 week (call for appt).
